Architectural close up of capital building

A Mission-Driven Approach

Together, we face evolving healthcare challenges, such as the ongoing worldwide battle against infectious diseases and a global rise in the incidence of noncommunicable diseases (NCDs), in a time of increasingly constrained healthcare resources.

We empower people worldwide to live healthier at every stage of life through access, leadership and partnership. Our policy vision for a healthy future focuses on advancing access to quality medicines; strengthening resilient, global supply chains; and building future access.



Global Issue Briefs

Global Supply Chains for Medicines

Secure, reliable access to medicines is best supported by a diverse and agile global supply chain designed to respond quickly to evolving needs. No country can make every medicine it needs, and no medicine is made in every country. Protectionism and localization will not improve overall supply resiliency; policies supporting strong global supply networks are needed.

Read More

Security of Medicines Supply

The global availability of safe, effective, and affordable medicines is threatened by systemic issues causing supply disruptions and medicine shortages. Stakeholder collaboration and policy action is urgently needed, and solutions must be targeted to the root causes of shortages. There is potential for misguided unilateral responses, such as supply chain localization requirements, to exacerbate supply vulnerabilities.

Read More

Improvements to Existing Medicines

Improvements to Existing Medicines covers products based on known molecules that address healthcare system needs and deliver relevant improvement for patients, healthcare professionals, and payers. A dedicated regulatory pathway for abbreviated development should be established for improvements to existing medicines that encompasses drug repurposing, drug reformulation, and drug combinations. Further, improvements to existing medicines should be recognized as a separate category of innovation with the appropriate incentives, including appropriate and proportionate exclusivity protections and pricing & reimbursement frameworks that recognize the value differentiated products offer to improve patient access and health outcomes while reducing health system costs.

Read More

Protecting Access to Antibiotics

Antimicrobial resistance (AMR) is a growing public health concern. Access to the right antibiotic at the right time is crucial in the fight against AMR, yet supply is threatened by the unsustainable market dynamics of off-patent antibiotics. Short- and long-term policy action is needed to safeguard access.

Read More

Global Regulatory Efficiencies

Streamlining regulatory frameworks that support the development, approval, and post-approval changes of medicines worldwide optimizes the use of both industry and health authority resources to create more efficient regulatory assessments, ultimately accelerating and expanding access for patients. Streamlining can be accomplished through harmonization, reliance, and agility, which expedites medicine approvals and enhances availability while upholding rigorous safety and efficacy standards.

Read More
Image of woman kissing baby

Commitment to U.S. Policy Solutions

Because of our unwavering belief that better access leads to better health, Viatris champions policies that reduce barriers to treatment.

Learn more


Championing Access for EU Patients

We are dedicated to sharing our perspectives on issues impacting patient access to medicines and engaging with the EU policy community.

Learn more

Access

Access

Patients everywhere need access to the right treatment at the right time. Because of our unwavering belief that better access leads to better health, Viatris champions policies that reduce barriers to treatment access, helping to achieve better health for patients and unlocking value for health systems.

Securing stable access to medicine for current and future patients can only be achieved through policy dialogue and collaboration. We are committed to bridging traditional divides in search of solutions.

Leadership

Leadership

We aim to provide stable, credible leadership in the evolution of healthcare.

Our global reach combined with our uniquely diverse product portfolio allows us to bring new solutions for the differentiated needs of patients and health systems around the world. We recognize the benefits of both innovation and competition in sustaining the delivery of high quality, affordable medicine to patients everywhere, today and tomorrow.

Partnership

Partnership

We partner with governments, healthcare providers, patient organizations and other stakeholders in search of solutions. Together, we can build sustainable systems for stable access and deliver better results for all.

As the world’s healthcare needs evolve, our GLOBAL HEALTHCARE GATEWAY® offers partners ready access to expanded markets through an innovative global infrastructure that connects people around the world to the high quality medicines and services they need, improving value for healthcare systems and seeking better health outcomes for patients.

Global Healthcare Gateway

Our commitment to policy engagement is unwavering. Together we can find innovative solutions to our common challenges, empowering people worldwide to live healthier at every stage of life.

Global Sustainability

Global sustainability is core to our business and purpose. We are committed to sustainability through our efforts that focus on access, the environment and inclusion. We strive to make a positive impact through leadership, cross-functional relationships and transparent reporting. By partnering with stakeholders throughout the globe, we are addressing some of the world’s most pressing health, environmental and social issues.

Learn about our impact